"V体育安卓版" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2020 Oct 9;21(1):842.
doi: 10.1186/s13063-020-04771-8.

Efficacy of one-stage cartilage repair using allogeneic mesenchymal stromal cells and autologous chondron transplantation (IMPACT) compared to nonsurgical treatment for focal articular cartilage lesions of the knee: study protocol for a crossover randomized controlled trial

J V Korpershoek  1 , L A Vonk  1   2 , E C Kester  1 , L B Creemers  1 , T S de Windt  1 , M M A Kip  3 , D B F Saris  1   4 , R J H Custers  5
Affiliations

Efficacy of one-stage cartilage repair using allogeneic mesenchymal stromal cells and autologous chondron transplantation (IMPACT) compared to nonsurgical treatment for focal articular cartilage lesions of the knee: study protocol for a crossover randomized controlled trial

J V Korpershoek et al. Trials. .

Abstract

Background: Articular cartilage defects in the knee have poor intrinsic healing capacity and may lead to functional disability and osteoarthritis (OA). "Instant MSC Product accompanying Autologous Chondron Transplantation" (IMPACT) combines rapidly isolated recycled autologous chondrons with allogeneic MSCs in a one-stage surgery. IMPACT was successfully executed in a first-in-man investigator-driven phase I/II clinical trial in 35 patients. The purpose of this study is to compare the efficacy of IMPACT to nonsurgical treatment for the treatment of large (2-8 cm2) articular cartilage defects in the knee. VSports手机版.

Methods: Sixty patients will be randomized to receive nonsurgical care or IMPACT. After 9 months of nonsurgical care, patients in the control group are allowed to receive IMPACT surgery. The Knee Injury and Osteoarthritis Outcome Score (KOOS), pain (numeric rating scale, NRS), and EuroQol five dimensions five levels (EQ5D-5 L) will be used to compare outcomes at baseline and 3, 6, 9, 12, and 18 months after inclusion V体育安卓版. Cartilage formation will be assessed at baseline, and 6 and 18 months after inclusion using MRI. An independent rheumatologist will monitor the onset of a potential inflammatory response. (Severe) adverse events will be recorded. Lastly, the difference between IMPACT and nonsurgical care in terms of societal costs will be assessed by monitoring healthcare resource use and productivity losses during the study period. A health economic model will be developed to estimate the incremental cost-effectiveness ratio of IMPACT vs. nonsurgical treatment in terms of costs per quality adjusted life year over a 5-year time horizon. .

Discussion: This study is designed to evaluate the efficacy of IMPACT compared to nonsurgical care. Additionally, safety of IMPACT will be assessed in 30 to 60 patients V体育ios版. Lastly, this study will evaluate the cost-effectiveness of IMPACT compared to nonsurgical care. .

Trial registration: NL67161. 000. 18 [Registry ID: CCMO] 2018#003470#27 [EU-CTR; registered on 26 March 2019] NCT04236739 [ ClinicalTrials. gov ] [registered after start of inclusion; 22 January 2020]. VSports最新版本.

Keywords: Advanced therapy medicinal product (ATMP); Articular cartilage defect; Chondrocytes; Chondrons; Crossover design; Knee; Mesenchymal stromal cells (MSC); Randomized controlled trial (RCT); Surgery. V体育平台登录.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Buckwalter JA. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther. 1998;28:192–202. doi: 10.2519/jospt.1998.28.4.192. - DOI - PubMed
    1. Gelber AC, Hochberg MC, Mead LA, Wang N, Wigley FM, Klag MJ. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med. 2000;133:321–328. doi: 10.7326/0003-4819-133-5-200009050-00007. - DOI - PubMed
    1. Pisanu G, Cottino U, Rosso F, Blonna D, Marmotti AG, Bertolo C, et al. Large osteochondral allografts of the knee: surgical technique and indications. Joints. 2018;6:42–53. doi: 10.1055/s-0038-1636925. - DOI - PMC - PubMed
    1. Brix M, Kaipel M, Kellner R, Schreiner M, Apprich S, Boszotta H, et al. Successful osteoconduction but limited cartilage tissue quality following osteochondral repair by a cell-free multilayered nano-composite scaffold at the knee. Int Orthop. 2016;40:625–632. doi: 10.1007/s00264-016-3118-2. - DOI - PubMed
    1. Christensen BB, Foldager CB, Jensen J, Jensen NC, Lind M. Poor osteochondral repair by a biomimetic collagen scaffold: 1- to 3-year clinical and radiological follow-up. Knee Surg Sport Traumatol Arthrosc. 2016;24:2380–2387. doi: 10.1007/s00167-015-3538-3. - DOI - PubMed

Publication types

MeSH terms

Associated data (V体育平台登录)